@ravenn.co: Attention - Charlie Puth >>>🎧 || #attention #charlieputh #lyrics #fyp #foryou

raven.
raven.
Open In TikTok:
Region: ID
Thursday 20 November 2025 17:38:07 GMT
932506
97310
145
4962

Music

Download

Comments

cabaimari
cabaimari!!! :
2025-11-21 13:36:25
706
whoyaya_34
wht? :
"you just want attention, you don't want my heart" 😢
2025-11-27 03:30:08
27
engineren143
•♡:)engene girl(:•♡ :
"Your just a Samsung"
2025-11-21 15:08:18
250
damonla5
Kajalar :
2025-12-05 03:24:46
59
faizaaa1731
~💜فاءزة ~ :
beautiful song
2025-11-21 12:55:54
26
ra.fi.2.0
𝐄𝐧𝐳𝐨 :
This Song Owner
2026-01-09 02:48:06
4
na199_8
﹄ أبو جاسم 515 ﹃ :
2025-12-06 18:26:11
9
niveenkhalil_
Niveen Khalil🇱🇧 :
i KNEW* from the start💔
2025-11-21 16:06:42
8
badar_chaudhary_
BADAR Ali ! بدر علی 🇸🇦 :
2025-12-30 08:13:55
5
radz995
🐎 🦅 :
2025-11-22 20:14:51
54
jasalfakih
JoJo :
Ich will nur dein Herz …..
2025-11-23 09:01:24
7
bmw_lm5
مصطفى السومري :
2025-12-09 17:51:47
11
shensenn26
— sen Voldigoat! :
2025-11-23 17:25:14
51
aethercut26
Aethercut :
2025-12-07 06:50:52
13
tunsi.111
🇹🇳 :
just
2025-11-25 21:01:30
18
duo.ampek3
duo ampek :
2025-11-25 14:38:21
6
fa1_ema
🧷Tema fan :
💋❤
2025-11-23 04:50:02
7
yhaa875
yaya🤸 :
sama ga sih😭
2025-12-25 13:42:59
15
lolo68997
𝘼𝙡𝙖𝙖 ✨ :
my favourite song ❤️❤️❤️❤️❤️
2026-01-13 21:31:40
2
rihemsss
rihem ✨ :
2026-02-06 12:02:36
1
_the.gioi.lop_
lạnh thì Eom Ahn🤷🏻‍♀️. :
Đúng thế ko hả ôg bầu🗣️
2026-01-01 03:09:42
2
j.jha2
جوراجات :
This music and this world
2025-11-27 13:42:50
4
langenam
L∆NG :
song namee pls
2025-11-29 08:43:02
4
toylokaz067
️ :
ig: hrrsn.khl aquí los 1%
2025-12-28 06:08:10
1
bashar_gholifan
بشار غليفان :
2025-12-21 12:06:17
1
To see more videos from user @ravenn.co, please go to the Tikwm homepage.

Other Videos

Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only.  ------  What is HEMLIBRA?  HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors.  ------  What is the most important information I should know about HEMLIBRA?  HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots.  --  These serious side effects include:  • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs  • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head  --  Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total.  --  Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds).  --  The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information.
Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only. ------ What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. ------ What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots. -- These serious side effects include: • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head -- Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total. -- Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds). -- The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information.

About